In contrast to DPEP1, mechanistic studies regarding CD73-positive EVs in cancer are more established, including a report that CD73 is enzymatically active in B cells, although few studies are directly related to CRC[122]. This evidence concerns the gene NT5E and colorectal carcinoma.